BindingDB logo
myBDB logout

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28157311 11 Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors.EBI Novartis Institutes for BioMedical Research
27994744 16 Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D Inhibitors.EBI University of Michigan
24900375 4 Factor D Inhibitors for the Treatment of AMD: Patent Highlight.EBI TBA
 83 Thermodynamic and Nuclear Magnetic Resonance Study of the Interactions of alpha-and beta-Cyclodextrin with Model Substances: Phenethylamine, Ephedrines, and Related SubstancesBDB NIST
19645433 37 Novel flufenamic acid analogues as inhibitors of androgen receptor mediated transcription.BDB St. Jude Research Hospital
17585749 56 Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.BDB Amgen
7562908 46 Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.BDB University of Auckland
10508432 12 Design and fast synthesis of C-terminal duplicated potent C(2)-symmetric P1/P1'-modified HIV-1 protease inhibitors.BDB Uppsala University